Using a mouse model of APC-mutation-driven CRC, IL-25-activated intratumoral ILC2s promoted intestinal tumorigenesis through enhancing M-MDSC-mediated suppression of anti-tumor immunity. The gene discussed is IL25; the disease is neoplasm.